 Competence in quality of pharmaceuticals by quality benchmarking: a conceptual discussionR. Narayana Charyulu, V. Anoop Narayanan, D.S. Sandeep and N.R. Anupriya International Journal of Productivity and Quality Management, 2022, vol. 37, issue 2, 216-225 Abstract: Benchmarking is a strategic tool that can be used by companies for comparing with their competitors the acquisition of more information for the implementation of new processes to improve the effectiveness of the company. Pharmaceutical companies compete on many different levels, from the developmental process of the drug, to the marketing of the product. This article provides the applicability of the benchmarking process in different areas of a pharmaceutical company. This includes benchmarking of the product development process, quality management system, strategy, and marketing system, information service, call handling, stability testing studies, efficacy benchmarking, etc. Even though the benchmarking process is an effective method for the improvement of the efficacy of the company, it affects the competitors by reducing their ability to commercially exploit their information and preventing others from acquiring the information. Therefore, the benchmarking process undergoes some legal and ethical issues, which is governed by intellectual property laws and competition law. Keywords: quality; benchmarking; pharmaceuticals; quality management. (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:ids:ijpqma:v:37:y:2022:i:2:p:216-225 Access Statistics for this article More articles in International Journal of Productivity and Quality Management from Inderscience Enterprises Ltd |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.